Internal Receptors
Emerging Adulthood
Metastasis
The Eukaryotic Promoter Region
Co-activators and Co-repressors
Introduction Cardiac Emergencies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 13, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
Amando A Strong1, Marguerite S Buzza1,2,3,4, Toni M Antalis1,2,3,4
1Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland.
Tumor metastasis, a major cause of cancer death, involves Protease-activated receptor-2 (PAR-2) signaling. Repurposing PAR-2 inhibitors may offer new treatments for advanced cancers.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: